+ND Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Lightcastlightcast.bioinApr 2026 · $27M
Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.
BiotechDeep TechHealthtech
Co-investorsIllumina VenturesLongwall Venture Partners LLPM VenturesOMX VenturesARCH Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.